tiprankstipranks
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
SABS
SAB Biotherapeutics
RESEARCH TOOLSreports

SAB Biotherapeutics (SABS) Cash flow

Compare
316 Followers

SAB Biotherapeutics Cash Flow

SABS's free cash flow for Q4 2025 was $-17.71M. For the 2025 fiscal year, SABS's free cash flow was decreased by $-11.08M and operating cash flow was $-16.78M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Mar 25Dec 23Mar 23Dec 21
Operating Cash Flow
$ -44.78M$ -34.29M$ -25.12M$ -23.46M$ 1.99M
Investing Cash Flow
$ -121.71M$ -11.96M$ -152.70K$ -2.09M$ -10.94M
Financing Cash Flow
$ 168.30M$ -1.17M$ 66.77M$ 1.05M$ 35.89M
End Cash Position
$ 10.50M$ 8.90M$ 56.57M$ 15.05M$ 39.55M
Free Cash Flow
$ -45.71M$ -34.63M$ -25.32M$ -25.63M$ -8.96M
Currency in USD

SAB Biotherapeutics Cash Flow